Overview Founded in October 2012, Hillhouse Capital Advisors, Ltd. (“HCA”) provides investment advice
to clients organized as privately-offered pooled investment vehicles or similar structures (the
“Funds”) and to certain managed accounts or similar relationships. The Funds and all such
HCA-advised managed accounts are referred to herein as “clients.” HCA is a wholly-owned
subsidiary of Hillhouse Capital Group Limited, which itself is a wholly-owned subsidiary of
Hillhouse Capital Group Holdings Limited. Mr. Lei Zhang directly owns 100% of Hillhouse
Capital Group Holdings Limited. HCA is part of the “Hillhouse Capital Group,” a multinational
group of related advisory entities.
To comply with local operational requirements (including the issuance of local work visas),
HCA has engaged local affiliates based in Hong Kong, the People’s Republic of China (the
“PRC”), and Singapore (Hillhouse Capital Management Limited, Hillhouse (Beijing) Advisory
Limited, and Hillhouse Capital Management Pte. Ltd., respectively). While these local entities
are not registered as investment advisers with the United States Securities and Exchange
Commission (the “SEC”), because these entities are under common control with HCA and share
certain personnel and resources, HCA subjects these affiliates’ personnel to all of its compliance
policies and deems these affiliates’ books, records, and personnel to be within the scope of
HCA’s books and records retention and production obligations. Accordingly, certain
information on HCA contained in this Brochure, including information regarding personnel, is
presented on an aggregate basis for HCA and these affiliates.
Another HCA affiliate, Hillhouse Capital Management, Ltd. (“HCM”), which is discussed in
Item 10, is registered as an investment adviser with the SEC. While HCA and HCM may, from
time to time, invest in similar strategies or companies, HCA-advised clients generally focus on
publicly-listed (or similarly liquid) investment opportunities, while HCM-advised clients largely
focus on private (or otherwise less liquid) investment opportunities, including venture capital,
private equity, private debt and buyout transactions.
Investment Philosophy HCA’s investment philosophy is to seek long-term, risk-adjusted returns through bottom-up
analysis and fundamental proprietary research. As part of HCA’s bottom-up analysis, it
performs both qualitative and quantitative assessments of potential investments with a particular
focus on opportunities upon which it can gain insights and discover value in an ever-changing
world. HCA believes that this fundamental research persistence allows it to be a patient, long-
term investor.
Markets and Investment Opportunities
HCA primarily invests in equity and debt securities, but may invest in a wide range of securities
and other financial instruments including, without limitation: share capital; common and
preferred stock (privately-placed and exchange-traded); shares of beneficial interest; partnership
interests and similar financial instruments; bonds, notes, and debentures and other debt
instruments (whether subordinated, convertible, or otherwise); commodities; currencies; interest
rate, currency, commodity, equity, debt, and other derivative products (including, without
limitation, (i) futures contracts (and options on futures contracts) relating to stock indices,
currencies, other financial instruments, and all other commodities, (ii) swaps, options, warrants,
caps, collars, floors, and forward rate agreements, (iii) spot and forward currency transactions,
and (iv) agreements relating to or securing such transactions); equipment lease certificates;
equipment trust certificates; loans; accounts and notes receivable and payable held by trade or
other creditors; trade acceptances; contract and other claims; executory contracts; participations;
mutual funds; money market funds; structured securities; repurchase agreements; obligations of
governments and instrumentalities; commercial paper; certificates of deposit; bankers’
acceptances; trust receipts; choses in action; real estate, including fee interests, leaseholds,
mortgages, or other real estate assets; and any other obligations and instruments or evidences of
indebtedness of whatever kind or nature; in each case, of any person, corporation, government,
or other entity whatsoever, whether or not publicly traded or readily marketable. Some
investments that HCA makes for client accounts may have no readily available market.
HCA invests client assets in a wide range of countries, markets and exchanges in Asia and
throughout the world, including, without limitation, markets in the PRC, Hong Kong, the United
States (“U.S.”), Singapore, Taiwan, Korea, Japan, Indonesia, India, Vietnam, Malaysia,
Thailand, Australia, the United Kingdom, and elsewhere. Clients may also face indirect
exposure to all of the instruments and investments listed above through investment in special
purpose vehicles and similar entities.
Advisory Services HCA provides portfolio advisory services and manages client accounts and Funds on both a
discretionary and non-discretionary basis subject to any investment policies and restrictions
established by its clients. HCA manages the Funds in accordance with the investment guidelines
set forth in the offering documents for each Fund and manages other client accounts in
accordance with the authority delegated to it (including any limits on that authority) under the
applicable client’s investment management agreement or governing documents. HCA consults
with each client on its investment objectives and tailors its services and advice to those
objectives.
HCA had approximately $25.318 billion of assets under management as of January 1, 2019, with
approximately $2.110 billion managed on a non-discretionary basis and $23.208 billion managed
on a discretionary basis. The amount of assets under management reported in this Brochure is
lower than the amount of “regulatory assets under management” that HCA reports in Part 1, Item
5 of its Form ADV because Item 5 requires an adviser to report assets under management
inclusive of any uncalled commitments and
without deducting any outstanding indebtedness or
other accrued but unpaid liabilities. To prevent the appearance of an overstatement of HCA’s
assets under management, HCA has calculated assets under management in this Brochure
exclusive of uncalled commitments and
taking into account certain unpaid liabilities and
outstanding indebtedness.
Fund Structures While there are no express limits on the kinds of Funds and other clients that HCA may advise,
nor on the composition of their portfolios (except on a client-specific basis as disclosed in
“Advisory Services” above and elsewhere in this Brochure), HCA’s client portfolios generally
focus on publicly-listed (or similarly liquid) investment opportunities. A smaller portion of the
Funds or their portfolios may also hold investments in illiquid or less-liquid investments.
Additionally, certain of HCA’s Funds may primarily invest in securities and other investment
instruments that are traded on exchanges within the PRC (such investments, “A Share
Investments”).
The Funds are often organized into master-feeder structures. A master-feeder structure is
commonly used to accumulate capital raised from U.S. taxable, U.S. tax-exempt, and non-U.S.
investors into one central trading vehicle – a master fund – in order to enhance the critical mass
of tradable assets, improve economies of scale under which the fund arrangements operate and
enhance operational efficiencies, thereby reducing costs. HCA commonly serves as, or controls,
or is under common control, with an entity that serves as, the general partner of those Funds
organized as partnerships. The general partner of any Fund may also act as the general partner of
other Funds or investment vehicles.
Co-Investments HCA or its affiliates may also, from time to time, form, sponsor, manage, arrange, offer or advise
investment vehicles or accounts in connection with a particular strategy or theme, or may
establish, sponsor or advise, on a transaction-by-transaction basis, an investment vehicle or
account through which certain persons may invest alongside or independently of one or more
clients (each such vehicle or account, a “Co-Investment Arrangement”). Co-Investment
Arrangements may participate in individual investments or a series of related or unrelated
investments alongside one or more other clients of HCA and its affiliates. Co-Investment
Arrangements may also make investments independently of (and not alongside) other clients of
HCA and its affiliates. In addition, certain Funds (and other HCA clients) may from time to time
co-invest with each other. HCA’s fee and compensation practices for Co-Investment
Arrangements are subject to a case-by-case agreement with the applicable investor.
The allocation of co-investment opportunities can be both discretionary or non-discretionary, and
HCA takes into account various facts and circumstances deemed relevant for determining
allocations relating to co-investment opportunities and establishing co-investment structures.
Such factors are likely to include, among others, the strategic value that the potential co-investor
may bring to the investment or transaction, whether a potential co-investor has expressed interest
in co-investment opportunities, the market or opportunity size, the amount of capital needed for
the potential investment, the number of investors that can practically participate in the
transaction, HCA’s assessment of the potential co-investor’s ability to invest in an amount and
within the timeframe required by the investment, regulatory or tax considerations in the
investment, the portfolio company’s requirements or preferences, and such other factors that
HCA may deem relevant. Please see “Investment Allocations” below for additional information
relating to investment allocations.
A Share Managed Account Clients Within its broader offering of advisory services, HCA provides advisory services with respect to
A Share Investments. A Share Investments can be made by persons licensed as a Qualified
Foreign Institutional Investor (“QFII”) by the China Securities Regulatory Commission (the
“CSRC”) (such investments, “QFII Investments”) as well as through the Shanghai – Hong Kong
Stock Connect and the Shenzhen – Hong Kong Stock Connect programs (collectively, the “Stock
Connect” programs). HCA advises clients holding QFII licenses in their trading of QFII
Investments and clients that invest in A Share Investments through the Stock Connect programs.
Client Eligibility and Focus. HCA has a select and limited number of managed account clients
that are eligible for its A Share Investment program (“A Share Managed Account Clients”) and,
thus, HCA consults with each A Share Managed Account Client on its investment objectives and
then tailors HCA’s services and advice to those objectives. HCA’s role is to advise its A Share
Managed Account Clients in the selection of A Share Investments most suited to their investment
objectives, and then to manage, monitor, and provide additional investment advice as required in
connection with the applicable advisory relationship. A Share Managed Account Clients may be
managed on a discretionary or non-discretionary basis.
Investment Allocations and Related Conflicts HCA faces a number of conflicts in allocating investment opportunities among its various
clients, including clients with similar or identical trading and investment programs and clients
that have separate and distinct, but overlapping, trading and investment programs. HCA may
also face additional allocation conflicts in connection with certain proprietary vehicles owned or
controlled by HCA and its affiliates. These conflicts are heightened by the fact that the various
Funds and other clients sponsored, advised, or managed by HCA and its various affiliates have
different management and incentive fee structures.
Not all of the opportunities that may be suitable for a given client will be presented to such
client. In some circumstances, HCA may allocate the same or similar trade or investment
opportunities among clients and proprietary vehicles. In other circumstances, HCA may allocate
investment opportunities to certain clients or to proprietary vehicles and not to other clients.
Where investment opportunities fall within the investment programs of more than one client,
HCA’s policy is to allocate investment opportunities among eligible clients fairly and equitably,
to the extent possible, over a period of time taking into account certain considerations, including
(i) any applicable investment parameters, (ii) contractual obligations, (iii) legal, tax, regulatory
and other considerations, and (iv) internal allocation policies. In an effort to ensure fairness in
the allocation of investment opportunities among HCA’s clients, HCA has adopted allocation
policies and procedures that take into account various factors, including: the suitability of the
investment for each of HCA’s clients; HCA’s clients’ investment objectives and strategies;
lifespans and closing dates of HCA’s Funds or client mandates; existing portfolio composition
and existing holdings; net asset value; liquidity and reserve levels; risk profile; actual or
projected future capacity for investment and the timing thereof; eligibility; the portfolio
company’s requirements or preferences; targeted rate of return; the stage of development of the
prospective portfolio company or other investments; legal, tax, contractual, regulatory or other
considerations; cash levels and cash availability; anticipated holding period and remaining
investment periods; market exposure; market or opportunity size; currency exposure; and
industry sector exposure. To the extent that all or a portion of an investment opportunity is
deemed inappropriate for HCA’s clients, such as but not limited to investments in pooled
investment vehicles or similar structures managed by third parties that assess management fees
or performance fees/allocations, HCA, its employees and its affiliates may participate in such
opportunities as described in HCA’s policies and procedures.
please register to get more info
General Clients typically compensate HCA, in part, on the basis of asset management fees calculated as a
percentage of a client’s assets under management, or may, in certain instances, be calculated as a
percentage of a client’s funded and unfunded capital commitments. HCA generally deducts or
charges asset management fees from or to client accounts on a quarterly basis and such fee rates
are individually negotiated with HCA’s clients. Asset management fees are generally payable by
clients in advance of the beginning of each calendar quarter.
HCA also enters into arrangements to receive performance-based fees/allocations. In such cases,
HCA generally assesses performance-based fees/allocations based on realized and unrealized
capital appreciation, if any, over a threshold amount, such as a hurdle, benchmark or preferred
return. HCA generally deducts or receives a portion of performance-based fees/allocations from
client accounts, or collects or receives them directly from clients on an annual basis. HCA’s fee
and compensation practices for Co-Investment Arrangements are subject to a case-by-case
agreement with the applicable client. Performance-based fee/allocation rates are individually
negotiated with HCA’s clients.
Neither HCA nor any of its “supervised persons” (as defined in the glossary of terms to the SEC
Form ADV) accept compensation for the sale of securities or other investment products,
including asset-based sales charges or service fees from the sale of mutual funds.
Performance-Based Compensation HCA receives performance-based fees and allocations, as described above. HCA negotiates or
arranges such fees/allocations with clients before entering into advisory relationships. The
receipt of performance-based compensation may create an incentive for HCA to make
investments that are riskier or more speculative than those HCA would otherwise make in the
absence of such incentive compensation. HCA addresses this conflict by focusing on long-term
relationships with its clients and Fund investors, and by managing client assets in accordance
with the applicable advisory agreement and/or governing documents.
HCA charges clients both asset-based fees and performance-based fees/allocations. However,
fees and other economic terms can be negotiated on a client-by-client basis and may vary.
Charging asset-based fees and performance-based fees/allocations may create a conflict of
interest because it creates an incentive to allocate the best-performing assets into client accounts
on which HCA charges performance-based fees/allocations. Additionally, the allocation of
performance fees and allocations at different rates, or subject to different hurdle rates or
preferred returns, may create an incentive for HCA or its affiliates to disproportionately allocate
time, services, or functions to accounts or vehicles with higher fees/allocations (or subject to a
lower hurdle rate or preferred return), or to allocate investment opportunities to such accounts or
vehicles.
HCA and its advisory affiliates recognize the possibility of such a conflict and address it through
HCA’s allocation policies and procedures and other relevant measures. Please see Item 4,
“Investment Allocations” for additional information on HCA’s investment allocation policies
and procedures. HCA does not charge performance-based fees where such an arrangement
would violate Section 205 of the U.S. Investment Advisers Act of 1940 (the “Advisers Act”)
pursuant to Rule 205-3 thereunder.
Valuation of Assets
The asset management fees and the performance-based fees/allocations charged to or made by a
client may be calculated based on valuations ascribed to the client’s holdings by HCA, which
presents a potential conflict. Valuations are also used for determining the prices at which
interests in Funds are redeemed or purchased, which underscores the importance of the need to
address any such conflict. HCA addresses this conflict by adhering to its valuation practices,
which include:
Engaging third party administrators, auditors, pricing sources, and valuation agents, from
time to time, to assist in certain valuation processes and confirmations; and
A Valuation Committee that seeks to implement HCA's valuation policies and procedures
and to make determinations and recommendations regarding the valuations ascribed to
client holdings.
HCA’s valuation policies and procedures (i) seek to ensure that HCA’s determination of fair
value of client assets is appropriate, (ii) require all such determinations to be made in good faith,
and (iii) address relevant accounting standards.
Specific valuation procedures may differ based on the type of security and/or instrument and the
observability of market inputs. Certain terms related to HCA’s valuation policies and procedures
are incorporated into written investment management agreements entered into with its clients
and/or the Funds’ governing documents. There can be no assurance that the value assigned to an
investment at a certain time will equal the value that the client is ultimately able to realize.
Expenses and Other Fees
Each client bears its own expenses and HCA’s general policy is that it will only assess expenses
against client accounts to the extent that such expenses are permissible client expenses under the
applicable client agreements. Allocable client expenses generally include: management fees and
performance fees/allocations; organizational and administration fees and expenses; taxes; costs
incurred in connection with the researching, evaluation, acquisition, monitoring and disposition
of investments (whether or not consummated); transaction costs; financing costs; insurance costs;
certain regulatory and tax compliance costs; and fees relating to service providers engaged for
the client’s business and operations, including, without limitation, attorneys, auditors,
accountants, valuation services, consultants, and custodians; and such other fees and expenses as
are provided for under the arrangement with each client.
Certain expenses may be charged to more than one client, in which case HCA will determine the
appropriate allocation of expenses among each client depending on the nature of the expense.
Certain expenses may be allocated between clients on a pro rata basis (as appropriate) while
others may be allocated more specifically based on other factors, such as the relevant clients that
have incurred the cost or received the benefit arising from the expenses. Clients will incur
brokerage and other transaction costs. Please see Item 12, “Brokerage Practices,” below for a
discussion of certain brokerage expenses. HCA has no affiliated broker-dealers.
HCA or its affiliates may receive or be eligible to receive other fees or service payments
(including directors’ fees, transaction fees, break fees, or similar fees) from client portfolio
investments, which may be in addition to management fees. As set forth in the governing
documents of the applicable client, HCA may, in some circumstances, be obligated to reduce the
amount of management fees paid by the relevant client based on such fees received. In addition,
HCA may forgo such fees or ensure such fees are received by the applicable client.
Refunds and Fee Waivers In the event of the termination of a client’s advisory contract during a quarterly period, the client,
without request, will receive a pro rata refund of the portion of the asset management fee paid in
advance for the remaining balance of the quarter. Additionally, HCA assesses a pro rata asset
management fee to any client account created on any date other than the first day of any calendar
quarter.
HCA may, in its sole discretion, waive all or part of any fees or expenses payable by or
attributable to its clients, their underlying investors, or their assets.
HCA, its affiliates and/or each of their personnel may invest in one or more of its Funds directly
or indirectly through vehicles established by HCA or its affiliates for personnel. HCA, its
affiliates and/or its or its affiliates’ personnel are not generally subject to asset management fees
or performance-based fees/allocations with respect to their investments in the Funds.
please register to get more info
HCA receives performance-based compensation as described in Item 5, “Fees and
Compensation” above. As described above, HCA does not engage in side-by-side management
practices.
please register to get more info
HCA serves as an investment adviser to pooled investment vehicles whose underlying investors
are exclusively “accredited investors” (as defined in Rule 501(a) of Regulation D under the U.S.
Securities Act of 1933) and “qualified purchasers” (as defined in Section 2(a)(51) of the U.S.
Investment Company Act of 1940). Underlying investors in the pooled investment vehicles
HCA advises are generally endowments, foundations, non-profit organizations, pensions,
corporates, government entities, family offices, trusts, and other businesses or institutions.
HCA also provides investment advice to institutional clients, such as endowments, foundations,
non-profit organizations, pensions, corporates, government entities, family offices, trusts, and
other businesses or institutions.
Minimum Account Size Certain of the Funds require an initial minimum capital contribution of $5,000,000 and minimum
subsequent capital contributions of $1,000,000, but the general partners of such Funds may
accept contributions in lesser amounts in their sole and absolute discretion, with an absolute
minimum initial capital contribution of $100,000 (except with respect to certain Funds and/or
affiliated investors). HCA generally does not require clients or investors to maintain a minimum
investment to continue an advisory relationships or to remain invested in the Funds.
Advisory Agreements All clients must enter into a written investment management, advisory, or similar agreement
before establishing an advisory relationship with HCA. HCA may not assign such agreements
without client consent.
please register to get more info
Methods of Analysis HCA’s research process employs fundamental, quantitative, and qualitative analysis, including
cyclical analysis. HCA focuses on developing a deep, fundamental understanding of investment
opportunities through rigorous due diligence and analysis. HCA’s bottom-up approach to
analysis and research is generally conducted on a company-by-company basis, but may extend to
competitors and industries. HCA evaluates the upside and downside of the companies and
opportunities identified and monitor them closely. HCA also conducts on-site visits, cross-
checks, and detailed financial analysis of investment opportunities. HCA’s analysis includes
vigilant monitoring that continues the due diligence process after an investment is entered into
the client’s portfolio. HCA’s extensive due diligence process also assists it in discovering and
exploring previously unknown investment opportunities.
Sources of Information HCA incorporates local expertise stemming from grassroots research to generate powerful
independent and proprietary views that drive its investment strategy. HCA generally adheres to
an exhaustive research framework, including face-to-face communication with management,
analysis of publications and other media, site visits, and dialogue with suppliers, customers, and
competitors.
Investment Strategies General Strategy. HCA’s investment decisions are based on bottom-up analysis and research.
HCA generally focuses on publicly-listed (or similarly liquid) investment opportunities across
multiple industries, but it may also participate in private (or otherwise less liquid) investment
opportunities. HCA invests primarily in reasonably priced companies that provide substantial
long-term growth prospects. Although HCA monitors macro-economic factors and market
trends, HCA generally avoids market-timing strategies and focuses primarily on bottom-up
opportunities.
HCA invests globally with a particular focus on companies or assets having substantial relations
with Asia. HCA focuses on understanding fundamental risks, uncovering long-term growth
potential, and targeting industries that it understands and can monitor.
Short Strategy and Hedging. HCA may, from time to time, utilize short sales and maintain
short positions in order to hedge risks that are present in or that could affect a client portfolio, to
generate returns for a client account, or to structure and manage risks in an investment strategy.
HCA is cognizant of the risks of trading short and monitors exposure carefully. Current
regulations on A Share Investments place limits on the ability to engage in short sales with
respect to such instruments, which may affect certain clients’ portfolios. These limits may or
may not be revised in the future.
Risk Factors Clients should be aware that any investment with HCA involves a high degree of risk and is
suitable only for investors of substantial means who have no need for liquidity with respect to the
amount invested and can afford to lose all of their investment. There can be no assurances that
HCA’s clients will receive a return of, or on, their capital.
Investors are advised to review the applicable Fund offering materials for a more extensive description of the risks of investing in the Funds.
General Risks.
Investment risks include, but are not limited to, the following:
Risk of Loss. HCA does not guarantee the future performance of any client portfolio, the
success of any investment decision, strategy, or advice that HCA may employ or provide, or the
success of HCA’s overall management of any client. Any investment made in connection with
HCA’s advice or management involves significant risk, including the risk of loss of all or
substantially all capital invested. Investors should be prepared to bear the loss of the entire
amount of their investment.
International Investments Risk. HCA’s investments include equity and debt securities in a
number of international jurisdictions including securities with a substantial relationship with
Asia. International investments involve a broad range of political, economic, legal, tax, and
financial risks. Many of these risks are not typically associated with investments in securities of
companies in economies that have developed and been regulated over a longer period. These
risks include: (i) less publicly available information; (ii) varying levels of governmental
regulation and supervision; and (iii) foreign exchange controls.
Moreover, non-U.S. companies may not be subject to uniform accounting, auditing, and financial
reporting standards, practices, and requirements comparable to those applicable to U.S.
companies. Further, investing in securities of non-U.S. entities that are generally denominated in
non-U.S. currencies and utilization of options on non-U.S. securities involves certain
considerations comprising both risks and opportunities not typically associated with investing in
securities of the U.S. government or entities organized or domiciled in the U.S. These
considerations include changes in exchange rates and exchange control regulations; political and
social instability; expropriation; imposition of foreign taxes; less liquid markets and less
available information than is generally the case in the U.S.; higher transaction costs; foreign
government restrictions; less government supervision of exchanges, brokers and issuers; greater
risks associated with counterparties and settlement; difficulty in enforcing contractual
obligations; and greater price volatility.
Further, income or proceeds received by a client from sources within some countries may be
reduced by withholding and other taxes imposed by such countries. Any such taxes paid by a
client will reduce its net income or return from such investments.
Emerging Markets Risk. Investing in an emerging market involves additional risks and special
considerations not typically associated with investing in other more established economies or
securities markets. Emerging economies differ from other large economies in many respects,
including the level of development, growth rate, and allocation of resources.
Such risks may include: (i) increased risk of nationalization, expropriation of assets, or
confiscatory taxation; (ii) greater social, economic, and political uncertainty, including war; (iii)
higher dependence on exports and the corresponding importance of international trade; (iv)
greater volatility, less liquidity, and smaller capitalization of securities markets; (v) greater
volatility in currency exchange rates; (vi) greater risk of inflation; (vii) greater controls on
foreign investment and limitations on repatriation of invested capital and on the ability to
exchange local currencies for U.S. dollars; (viii) increased likelihood of governmental decisions
to cease support of economic reform programs or to impose centrally planned economies; (ix)
differences in auditing and financial reporting standards, which may result in the unavailability
of material information about issuers; (x) less extensive regulation of the securities markets; (xi)
longer settlement periods for securities transactions and less reliable clearance and custody
arrangements; (xii) less protection through registration of assets; (xiii) less developed corporate
laws regarding fiduciary duties of officers and directors and protection of shareholders and other
interest holders; and (xiv) less developed laws regarding internal controls designed to ensure the
accuracy of financial reporting and third-party attestation of the effectiveness of those controls.
Moreover, the value of HCA’s investments may be adversely affected by uncertainties associated
with international political developments. Changes in political, economic, and social conditions
and government policies in the PRC and elsewhere in Asia may have a substantial detrimental
impact on HCA’s clients’ investments. These changes may include: (i) promulgation of new
laws, regulations, and economic policies; (ii) changes in the interpretation or enforcement of
laws or regulations; (iii) introduction of measures to control inflation or stimulate growth; (iv)
changes in the rate or method of taxation; and (v) the imposition of additional restrictions on
currency conversion and remittances abroad.
Availability of Suitable Investment Opportunities and Investment Risk. For HCA’s investment
strategies to be successful, it must be able to identify and select appropriate investment
opportunities. Additionally, HCA competes for investment opportunities with operating
companies, financial institutions, and other institutional investors, including hedge and other
investment funds, which may negatively impact HCA’s ability to take advantage of suitable
investment opportunities. Successful implementation of the investment strategy adopted by
HCA requires accurate assessments of general economic conditions, the detailed analysis of
individual companies or industries, the relationship between a security and its derivatives, the
risk correlation between a wide variety of investments, and the future behavior of other financial
market participants. Even with the most careful analysis, the direction of the financial markets is
often driven by unforeseeable economic, political, and other events and the reaction of market
participants to these events. HCA’s clients should be aware that the value of their investments
and the return derived from them may fluctuate. There can be no assurance that HCA’s strategy
will be successful and an unsuccessful strategy may result in significant losses to HCA’s clients’
investments. Further, there can be no assurance that the investments HCA chooses will achieve
its clients’ investment objectives. Additionally, though investments are monitored in accordance
with HCA’s policies, as well as risk management policies and restrictions in prospectuses,
investment advisory agreements or governing documents, there can be no guarantee that losses
will be avoided at all times. There is a risk that HCA’s clients’ investments will be lost entirely
or in part. Past performance should not be construed as an indication of the future results of an
investment that HCA monitors, recommends, or trades for its clients.
Strategy Risk. Fundamental analysis, by itself, does not attempt to anticipate market
movements. This presents a potential risk and, although HCA considers overall market
conditions in its investment strategies, the price of a security may move up or down along with
the overall market regardless of the economic and financial factors considered in evaluating the
investment. Likewise, HCA’s long-term growth strategy may not take advantage of short-term
gains that could be profitable. If HCA’s predictions are incorrect, a security may decline sharply
in value before client investments are sold.
Hedging Policies/Risks. In connection with the consummation of investments, HCA’s client
may or may not employ hedging techniques designed to protect such clients against adverse
movements in currency or prices. In the event as client does employ hedging techniques, it will
do so in order to: (i) protect against possible changes in the market value of the client’s
investment portfolio resulting from fluctuations in the markets and changes in interest rates;
(ii) protect the client’s unrealized gains in the value of its investment portfolio; (iii) facilitate the
sale of any securities; (iv) enhance or preserve returns, spreads or gains on any security in the
client’s portfolio; (v) hedge against a directional trade; (vi) hedge the interest rate, credit or
currency exchange rate on any of the client’s securities; (vii) protect against any increase in the
price of any securities the client anticipates purchasing at a later date; or (viii) act for any other
reason that HCA deems appropriate. HCA’s clients will not be required to hedge any particular
risk in connection with a particular transaction or its portfolio generally. HCA may be unable to
anticipate the occurrence of a particular risk and, therefore, may be unable to attempt to hedge
against it. While HCA’s clients may enter into hedging transactions to seek to reduce risk, such
transactions may result in a poorer overall performance for HCA’s clients than if they had not
engaged in any such hedging transaction. Moreover, the portfolio will always be exposed to
certain risks that cannot be hedged.
Leverage and Borrowing.
Leverage for Investment Purposes. HCA’s clients may employ leverage in their investment
activities. The use of leverage will allow HCA’s clients to make additional investments, thereby
increasing their exposure to assets, such that their total assets may be greater than their capital.
However, leverage will also magnify the volatility of changes in the value of the clients’
portfolio. The effect of the use of leverage by HCA’s clients in a market that moves adversely to
their investments could result in losses to such clients, which would be greater than if such
clients were not leveraged.
Collateral. HCA’s clients may pledge their securities to counterparties in order to borrow or
otherwise obtain leverage for investment or other purposes. Should the securities pledged to
counterparties to secure HCA’s clients’ margin accounts decline in value, the clients could be
subject to a “margin call,” pursuant to which the clients must either deposit additional funds or
securities with the broker or suffer mandatory liquidation of the pledged securities to compensate
for the decline in value. The banks and dealers that provide financing to HCA’s clients can
apply essentially discretionary margin, “haircut,” financing and collateral valuation policies.
Changes by counterparties in any of the foregoing may result in large margin calls, loss of
financing and forced liquidations of positions at disadvantageous prices.
HCA’s clients also may borrow money from and/or enter into guarantees, pledges or financing
arrangements with third parties or investors to make investments or satisfy other obligations
outside of a brokerage arrangement. The terms of any such borrowings, guarantees, pledges or
financing arrangements may require HCA's Funds and other clients to pledge or encumber their
assets to provide security to any such counterparties. Borrowing arrangements involve costs and
expenses, which are generally for the account of the relevant client. Counterparties that provide
other types of asset-based or secured financing to HCA’s clients may have rights similar to those
of counterparties providing leverage. There can be no assurance that the clients will be able to
secure or maintain adequate financing.
Costs. Borrowings will be subject to interest, transaction and other costs, and other types of
leverage also involve transaction and other costs. Any such costs may or may not be recovered
by the return on the clients’ portfolios.
Equity Risk. Because of the nature of HCA’s investment strategies, clients are subject to the risk
that prices will fall over short or extended periods of time, and clients could lose all, or a
substantial portion, of the value of their investments.
Business Risk. Investments made by HCA’s clients may report poor results and industry and/or
economic trends and developments could have a greater impact on certain companies in
comparison to the market as a whole. The prices of these companies’ securities may decline in
response.
Interest Rate Fluctuations Risk. The prices of some of the financial derivative instruments that
HCA may advise its clients to invest in may be sensitive to interest rate fluctuations.
Unexpected fluctuations in interest rates could cause the corresponding prices of HCA’s clients’
long and short positions to move in directions that were not initially anticipated. Additionally,
interest rate increases generally will increase the costs of borrowing. To the extent that interest
rate assumptions underlie the hedge ratios implemented in hedging a particular position,
fluctuations in interest rates could invalidate those underlying assumptions and expose HCA’s
clients to losses.
Market Risk and Disruptions. The price of a security may decline in response to certain
tangible and intangible events and conditions, including, but not limited to: conditions directly
involving the issuers of the securities; general economic conditions; overall market changes;
local, regional, or global political, social, or economic instability; governmental responses to
economic conditions; and currency, interest rate, and commodity price fluctuations. Such events
are beyond HCA’s control and may be independent of a security’s particular underlying
circumstances. Further, the global financial markets have undergone and may further undergo
pervasive and fundamental disruptions that have led to extensive and unprecedented
governmental intervention. Such intervention has, in certain cases, been implemented on a
sudden and “emergency” basis. This has substantially limited the ability of market participants
to continue to implement certain strategies or manage the risk of their outstanding positions. In
addition, as one would expect given the complexities of the financial markets and the limited
time frame within which governments have felt compelled to take action, these interventions
may be perceived as unclear in scope and application and such perceptions can contribute to
general uncertainty in the markets. Clients may incur major losses in the event of disrupted
markets and other extraordinary events in which historical pricing relationships (on which HCA
may base its advice) become materially distorted. The risk of loss from pricing distortions is
compounded by the fact that in disrupted markets many positions become illiquid, making it
difficult or impossible to close out positions against which the markets are moving. Market
disruptions may from time to time cause dramatic losses for HCA’s clients, and such events can
result in otherwise historically low-risk strategies performing with unprecedented volatility and
risk. It is impossible to predict what additional interim or permanent governmental restrictions
may be imposed on the markets and/or the effect of such restrictions on HCA’s strategies.
Derivative Instruments Risk. HCA may invest client assets in derivative instruments. The
prices of derivative instruments, including futures and options, are highly volatile. Payments
made pursuant to swap agreements may also be highly volatile. Price movements of futures and
options contracts and payments pursuant to swap agreements are influenced by, among other
things: interest rates; changing supply and demand relationships; trade, fiscal, monetary and
exchange control programs and policies of governments; and national and international political
and economic events and policies. The value of futures, options, and swap agreements also
depends upon the price of the assets underlying them. In addition, such instruments are subject
to counterparty risk. Certain options and other custom instruments are subject to the risk of non-
performance by the counterparty, including risks of creditworthiness of the counterparty, market
risk, liquidity risk, and operations risk. If a counterparty’s creditworthiness declines, the value of
any agreements with such counterparty can be expected to decline, potentially resulting in loss.
In connection with exchange-listed or centrally-cleared instruments, clients are subject to the risk
of failure of any of the clearing houses or clearing members through which their positions are
cleared.
Short-Selling Risk. HCA may engage in short-selling securities on behalf of its clients, which
involves: (i) selling securities which may or may not be owned by the short seller; and (ii)
borrowing them for delivery to the purchaser, with an obligation to replace the borrowed
securities at a later date. Short-selling allows a client to profit from a decline in market price to
the extent such decline exceeds the transactions costs and the costs of borrowing the securities.
A short sale creates the risk of a theoretically unlimited loss, in that the price of the underlying
security could theoretically increase without limit. This would in turn increase the cost to the
client of buying those securities to cover the short position. There can be no assurance that a
client will be able to maintain the ability to borrow securities sold short. In such cases, the client
can be “bought in” (i.e., forced to repurchase securities in the open market to return to the
lender). There also can be no assurance that the securities necessary to cover a short position
will be available for purchase at or near prices quoted in the market. Purchasing securities to
close out a short position can itself cause the price of the securities to rise further, thereby
exacerbating the loss. In addition, short-selling activities are subject to restrictions imposed by
other foreign governmental and regulatory authorities and various securities exchanges. Such
restrictions may inhibit or prevent HCA from entering into a short position on behalf of a client.
Investment Regulations Risk. The laws and regulations of various jurisdictions related to
securities markets, investment advisers, and pooled investment vehicles have undergone
substantial change in recent years, and such change may continue in the foreseeable future. The
effect of regulatory change on HCA and its clients, while impossible to predict, could be
substantial and adverse.
Securities Markets Risk. The PRC securities markets, including the Shanghai Stock Exchange
and Shenzhen Stock Exchange,
are undergoing a period of growth and change that may lead to
difficulties in the settlement and recording of transactions and in interpreting and applying the
relevant regulations. In addition, there is regulation and enforcement activity in the PRC
securities markets that may not be equivalent to markets in countries that are members of the
Organization for Economic Co-operation and Development (“OECD”), including the U.S. There
may not be regulation and monitoring of the PRC securities markets and activities of investors,
brokers, and other participants equivalent to that in certain OECD markets. Client investments
may be disrupted if changes are adopted in any applicable laws or regulations such that it
becomes illegal for the issuers to issue certain instruments. Such changes, if implemented, may
cause HCA’s clients to suffer substantial losses.
Liquidity Risk. Some companies or investments in which HCA’s clients invest may not be well
known, may have few shares outstanding, may have contractual or regulatory restrictions on
disposal, or may be particularly susceptible to political and economic events. Securities issued
by these companies may be difficult to buy or sell and the value of such securities may rise
and/or fall substantially before such securities may be bought or sold.
Currency Risk; Liquidity and Exchange Controls. Changes in currency prices may adversely
affect the base currency value of a client’s portfolio investments and gains and losses on the sale
of portfolio investments. Clients may also incur costs in converting investment proceeds from
one currency to another. At present,
renminbi (“RMB”) and certain other relevant currencies are
restricted currencies and are not freely convertible. Remittances or conversion of RMB and
certain other relevant currencies may be subject to approval from competent authorities. HCA’s
clients may be exposed to exchange control risk in connection with their investments. Relevant
authorities may change the current exchange control such that it may adversely impact the
liquidity of HCA’s clients’ investments and an active secondary market may not be developed or
maintained.
Nature of Investment. Certain clients may invest in companies that are experiencing or are
expected to experience severe financial difficulties, which difficulties may never be overcome.
Clients may also make investments in companies in a conceptual or early stage of development
that may not have a proven operating history on which to judge future performance. Such
investments are considered highly speculative and may result in the loss of the relevant clients’
entire investment. Since certain clients may only make a limited number of investments and
since many of HCA’s investments may involve a high degree of risk, poor performance by a few
of its investments could significantly reduce the total returns to such clients.
Third Party Involvement. HCA’s clients may co-invest in portfolio companies with one or more
third parties. Such investments may involve risks in connection with such third-party
involvement, including the possibility that a third-party co-investor may have financial, legal, or
regulatory difficulties, resulting in a negative impact on such investment, may have economic or
business interests or goals which are inconsistent with the relevant clients, or may be in a
position to take or block action in a manner contrary to such clients’ investment objectives. In
addition, the clients may, in certain circumstances, be liable for the actions of such third-party
co-investors. In circumstances where a management group is included as a third-party co-
investor, such third party may receive compensation arrangements relating to such investments,
including incentive compensation arrangements.
Reliance on the Management of Portfolio Companies. Although it is HCA’s intention to
ensure that portfolio companies have strong management teams, there can be no assurance that
any portfolio company’s management team will be able to operate successfully. With respect to
early-stage or recently developed investment opportunities, HCA may have limited ability to
evaluate the management of such companies based on past performance, and such companies
may rely more on individual members of the management team than would be the case for more
established companies. Instances of fraud and other deceptive practices committed by the
management teams of portfolio companies in which a client has an investment may undermine
HCA’s due diligence efforts with respect to such companies. If such fraud is discovered, it could
materially adversely affect the valuation of a client’s investments and may contribute to overall
market volatility that could negatively impact a client’s investments.
Uncertainty of Financial Projections. Projected operating results provided by companies or
generated internally will normally be based primarily on management or internal judgments. In
all cases, projections are only estimates of future results that are based upon assumptions made at
the time that the projections are developed. There can be no assurance that the projected results
will be obtained, and actual results may vary significantly from the projections. General
economic conditions, which are not predictable, can have a material adverse impact on the
reliability of projections.
Due Diligence Risk. Before making an investment in a private company, due diligence that is
deemed reasonable and appropriate based on the facts and circumstances applicable to each asset
or company will be conducted. Due diligence generally entails evaluation of important and
complex business, financial, tax, accounting, environmental and legal issues. Outside
consultants, legal advisors, accountants, investment banks and other third parties are involved
from time to time in the due diligence process to varying degrees depending on the type of
investment. Such involvement of third-party advisors or consultants may present a number of
risks primarily relating to reduced control of the functions that are outsourced. In addition, third-
party providers are unable to be engaged in a timely manner, its ability to evaluate and acquire
more complex targets could be adversely affected. When conducting due diligence and making
an assessment regarding an investment, HCA will rely on the resources available to it, including
information provided by the target of the investment and, in some circumstances, third-party
investigations. The due diligence investigation that HCA carries out with respect to any
investment opportunity may not reveal or highlight all relevant facts that are necessary or helpful
in evaluating such investment opportunity. Moreover, such an investigation will not necessarily
result in an investment in a company being successful.
Local Intermediary Risk. Client transactions may be undertaken through local brokers, banks, or
other organizations, and the clients will be subject to the risk of default, insolvency, or fraud of
such organizations. Such local brokers, banks, and other organizations are subject to various
laws and regulations in various jurisdictions that are designed to protect their customers in the
event of insolvency. However, the practical effect of these laws and their application to clients’
assets are subject to substantial limitations and uncertainties. There can be no assurance that any
money advanced to such organizations will be repaid or that the clients would have any recourse
in the event of default. The collection, transfer, and deposit of bearer securities and cash expose
clients to a variety of risks including theft, loss, and destruction.
Difficulty of Bringing Suit. The ability of a client to bring suit against a portfolio company or
its directors, executive officers, or other shareholders may be limited. Portfolio companies are
likely to be organized under the laws of countries other than the U.S., their directors and officers
are likely to reside outside of the U.S., and substantially all of their assets may be located outside
of the U.S. As a result, it is likely that a client will be unable to effect service of process within
the U.S. upon such entities or their directors and officers. Even where an entity is successfully
sued in the U.S., enforcement of the judgment in certain jurisdictions is impossible and in other
jurisdictions may be difficult.
Particular Risks Relating to A Share Investments
PRC Laws and Regulations Risk. The PRC legal system is a civil law system based on written
statutes. Since 1979, the PRC government has been developing a comprehensive system of
commercial laws and considerable progress has been made in the promulgation of laws and
regulations dealing with economic matters, such as corporate organization and governance,
foreign investment, commerce, taxation, and trade. Therefore, some degree of uncertainty exists
in connection with whether existing laws and regulations will apply to certain events or
circumstances and, if so, the manner of such application. Precedents on the interpretation,
implementation, and enforcement of PRC laws and regulations are somewhat limited and the
binding nature of decisions of PRC courts may vary. The administration of PRC laws and
regulations may be subject to a certain degree of discretion by executive authorities. In
particular, as mentioned below, new investment regulations have a shorter operating history.
Because these laws, regulations, and legal requirements are relatively recent, their interpretation
and enforcement involve some uncertainty. In addition, PRC laws governing business
organizations, bankruptcy, and insolvency have less of an operating history and precedence,
which could lead to less certainty on protections for security holders than that provided by the
laws of some other countries.
At present, the securities market and the regulatory framework for the securities industry in the
PRC is at an early stage of development. The CSRC is responsible for supervising the national
securities markets and producing relevant regulations. Additionally, such investment regulations
allow the CSRC and the PRC State Administration of Foreign Exchange (“SAFE”) considerable
discretion, which may result in uncertainty as to how this discretion may be exercised. Such
investment regulations may be varied in the future and may negatively impact HCA and its
clients. Investment quotas and currency matters may be subject to review from time to time by
the CSRC and SAFE.
Stock Connect and QFII Programs. Access to A Share Investments by foreign investors is
restricted under the PRC laws and regulations. Investors may apply directly for a QFII license,
after which they may apply for and obtain a quota of RMB with which to trade on the market, or
they may invest in A Share Investments through Stock Connect, or through derivative products
offered by certain investment banks and other financial institutions, each of which involves
particular risks and considerations, including limited availability, increased cost, suspension of or
limitations on trading and custody risks, among others. HCA’s clients may also seek to invest in
or obtain exposure to A Share Investments through other means, subject to compliance with
applicable laws and regulations, which may give rise to similar or other risks and considerations.
QFII status is only granted to investors who are able to meet stringent asset, experience, and
strategy requirements, including a minimum investment quota. Investors in A Share Investments
also operate under a number of other investment constraints. For example, there is currently
limited opportunity to short equities and to engage in derivative transactions on the applicable
markets. In addition, the QFII program offers restricted ability to rebalance and repatriate funds.
The unique restrictions, limits, and characteristics of the A Share Investment portfolio make
HCA’s investment advisory services with respect to A Share Investments particularized and
appropriate for investors focused on such investments. In addition, certain of HCA’s clients may
place specific investment or other limits on the investment advice it seeks.
Trading Volumes and Volatility Risk on PRC Exchanges. The Shanghai Stock Exchange and
Shenzhen Stock Exchange have lower trading volumes than many OECD exchanges and the
market capitalizations of listed companies are small compared to those on more developed
exchanges. The listed equity securities of many companies in the PRC are accordingly
materially less liquid, subject to greater dealing spreads, and experience materially greater
volatility than many securities in OECD countries. Government supervision and regulation of
the PRC securities market and of quoted companies may be considered less developed than in
some OECD countries. The PRC stock market has, in the past, experienced substantial price
volatility and no assurance can be given that such volatility will not occur in the future.
Disclosure of Shares and Short Swing Profit Rule. Under PRC disclosure of interest
requirements, clients investing in A Share Investments via Stock Connect or the QFII program
may be deemed to be acting in concert with other Funds managed by HCA and certain of its
affiliates or a substantial shareholder or client of HCA, and therefore may be subject to the risk
that the relevant client’s holdings may have to be reported in aggregate with the holdings of other
Funds or clients should the aggregate holding trigger the reporting threshold under PRC law,
which is currently 5% of the total issued shares of the relevant PRC listed company. This may
expose clients’ holdings to the public and may adversely impact the performance of such clients.
In addition, subject to the interpretation of PRC courts and PRC regulators, the operation of the
PRC short swing profit rule may be applicable to clients’ investments with the result that where
the holdings of such clients (possibly with the holdings of other investors deemed as concert
parties of the clients) exceed 5% of the total issued shares of a PRC listed company, the clients
may not reduce their holdings in such company within six months of the last purchase of shares
of such company. If clients violate the rule and sell any of their holdings in such company in the
six month period, they may be required by the listed company to return any profits realized from
such trading to the listed company. Moreover, under PRC civil procedures, the clients’ assets
may be frozen to the extent of the claims made by such company.
PRC Enterprise Income Tax. According to the Enterprise Income Tax Law of the PRC, which
became effective on January 1, 2008 (the “Enterprise Income Tax Law”), dividends, interest,
rents, royalties, capital gains, and other income from PRC sources recognized by non-PRC tax
resident enterprises are generally subject to PRC Enterprise Income Tax (“EIT”) at a rate of
20%, provided that (i) the non-PRC tax resident enterprise does not have an establishment or
place of business or a permanent establishment (the establishment/place of business and
permanent establishment are collectively referred to as “PE”) within China or (ii) although the
non-PRC tax resident enterprise has a PE within China, the income received by such non-PRC
tax resident enterprise has no actual connection with such PE. The implementation regulations
of the Enterprise Income Tax Law reduced the rate of EIT imposed by the Enterprise Income
Tax Law from 20% to 10% for PRC-sourced income recognized by non-PRC tax resident
enterprises under “non-PE” situations. In addition, the EIT rate may be reduced or exempted if
there is any applicable tax treaty or arrangement.
According to the
Notice on Issues relating to Withholding EIT of Dividends and Interests Paid
by a Resident Enterprise to a Qualified Foreign Institutional Investor (
Guoshuihan [2009]
No.47), issued on January 23, 2009 (the “QFII Withholding Tax Notice”), PRC tax authorities
confirmed that QFIIs will be subject to EIT at the rate of 10% on dividends and interests derived
from the PRC (subject to reduction by applying relevant tax treaties or
arrangements). Notwithstanding the above, according to the
Notice on EIT and Value-added Tax
Policies Relating to Foreign Institutions Investing in the PRC Bond Market (Caishui [2018]
No.108) (“Circular 108”) issued on November 7, 2018, during the time period between
November 7, 2018 and November 6, 2021, interests derived by a foreign institution (including
QFIIs) from its investments in the PRC bond market are exempted from EIT if (i) the QFII has
no PE within China or (ii) although the QFII has a PE within China, the interests received by the
QFII has no actual connection with such PRC PE. PRC resident enterprises who distribute
dividends to QFIIs shall withhold 10% EIT (unless relevant tax treaty preferential treatment
could apply), which can be expected to adversely affect returns in respect of any client’s QFII
Investment. QFIIs may apply for refund of any overpaid EIT if the QFII is eligible for a
preferential tax treaty rate, subject to the mainland China tax authorities’ discretion. Interests
derived from government bonds issued by the finance authority of the State Council and local
government bonds approved by the State Council shall be exempt from the EIT. The tax
exemption treatment for the latter kind of bonds applies to bonds issued on or after January 1,
2012.
Notice on Temporary Exemption of EIT on Income from Transfer of Equity Investment Assets
Including Shares Within China by QFII and RQFII (Caishui [2014] No.79) (“Circular No. 79
”),
which became effective on November 17, 2014, has provided a provisional exemption of PRC
EIT for capital gains derived by QFIIs from transfers of equity investment assets (e.g. A Share
Investments) of PRC enterprises, provided that (i) the QFII has no PE within China or (ii)
although the QFII has a PE within China, the capital gains received by the QFII has no actual
connection with such PE. In such conditions, it is likely that QFIIs will not be subject to PRC
EIT on capital gains generated from transfer of equity investment assets derived on or after
November 17, 2014. Circular No. 79 has also stipulated that any capital gains derived by QFIIs
from transfers of shares before November 17, 2014 shall be taxable and any unpaid tax shall be
collected.
Circular No.79 did not set an expiry date for such provisional exemption of PRC EIT on such
capital gains. Hence there is no guarantee that it may not be replaced or abolished by any
follow-up regulations. Clients’ QFII Investments may be materially adversely impacted if EIT is
imposed in the future or with respect to prior transactions, in particular in light of Circular No.
79.
In relation to capital gains realized from the disposal of PRC debt securities, technically
speaking, proceeds from the disposition of PRC debt securities by QFII should be subject to PRC
EIT at the rate of 10% (unless relevant tax treaty preferential treatment applies). Should the PRC
tax authorities decide to levy tax on such gains in the future, QFII Investments may be materially
adversely impacted.
The Notice of the Ministry of Finance (“MOF”), the State Administration of Taxation (“SAT”)
and the CSRC on Tax Collection Policies Relating to the Shanghai-Hong Kong Stock Connect
(Caishui [2014] No.81), which became effective on November 17, 2014, indicates that capital
gains generated from transfers of A Share Investments through the Shanghai-Hong Kong Stock
Connect are exempt from PRC EIT starting November 17, 2014.
The Notice of the MOF, the
SAT and the CSRC on Tax Collection Policies Relating to the Shenzhen-Hong Kong Stock
Connect (Caishui [2016] No.127), which became effective on December 5, 2016 indicates that
capital gains generated from transfers of A Share Investments through the Shenzhen-Hong Kong
Stock Connect should be exempted from PRC EIT starting December 5, 2016.
PRC Stamp Duty. PRC stamp duty is generally imposed on the purchase and sale of A Share
Investments in PRC publicly-traded companies at a rate of 0.1% of the value of such purchase
and sale. According to regulations effective September 19, 2008, the purchase of shares of PRC-
listed companies will not be subject to PRC stamp duty and only the selling party will be subject
to the PRC stamp duty for the transfer of shares. The holder of a QFII license is subject to PRC
stamp duty on each sale made in PRC-listed shares, which may adversely affect investment
returns.
PRC Value-added Tax (“VAT”) Risk. Pursuant to the
Circular on Full Implementation of
Transferring Business Tax to Value Added Tax Reform (Caishui [2016] No. 36) issued by the
MOF and the SAT on March 23, 2016 (the “VAT Circular”), VAT was introduced to replace
Business Tax for all business activities effective from May 1, 2016. VAT is applicable where
entities or individuals provide services within the PRC. The VAT Circular specifically provides
that QFIIs are exempt from VAT with respect to gains derived from their securities trading
activities in China via PRC trading agents. Furthermore, the
Supplementary Notice of the MOF
and the SAT on VAT Policies for Interbank Dealings of Financial Institutions (Caishui [2016]
No. 70), which came into effect retroactively on May 1, 2016 (the “Interbank VAT Circular”),
further clarifies that income derived from the investment in interbank local currency market (i.e.,
the interbank bond market) by a foreign institution which is duly recognized by the People’s
Bank of China shall be exempted from VAT. Therefore, once the conditions set forth by the
Interbank VAT Circular are satisfied, a QFII will also be exempted from VAT for its income
from certain interbank transactions. According to Circular 108, during the time period between
November 7, 2018 and November 6, 2021, interests derived from a foreign institution’s
(including a QFII’s) investments in PRC debt securities market are also exempted from PRC
VAT. If certain gains are exempted from VAT, they shall also be exempted from local
surcharges calculated based on VAT. According to the VAT Circular, interests received from
government bonds and local government bonds are exempt from VAT.
Risks Related to Less Liquid and Private Investments.
While HCA is generally focused on more liquid investment opportunities, HCA clients may also,
from time to time, invest in less liquid opportunities or private-equity opportunities with longer
lock-ups. These opportunities pose their own risks, including the following:
Additional Capital Requirements of Portfolio Companies. Certain of the clients’ portfolio
companies or pooled investment vehicle holdings, especially those in a development, acquisition,
or “platform” phase, may require additional financing to satisfy working capital requirements or
acquisition strategies. Following its initial investment in a company, a client may be called upon
to provide additional capital to, or have the opportunity to increase its investment in, an
investment opportunity. Although clients may make a follow-on investment, there is no
assurance that those clients and their co-investors (if any) will provide all necessary follow-on
capital. The amount of such additional financing will depend upon the maturity and objectives
of the particular portfolio company. Each such round of financing (whether from a Fund or other
investors) is typically intended to provide enough capital to reach the next major corporate
milestone. If the funds provided are not sufficient, a portfolio company may have to raise
additional capital at a price unfavorable to the existing investors, including the relevant client, or
there may be severe penalties for a failure to fund required contributions. In addition, a client or
such other investor may make additional debt and equity investments or exercise warrants,
options or convertible securities that were acquired in the initial investment in a portfolio
company in order to preserve the Fund’s proportionate ownership when a subsequent financing
is planned, or to protect the investor’s investment when such portfolio company’s performance
does not meet expectations. The availability of capital is generally a function of capital market
conditions that are beyond the control of an investor or any portfolio company. There can be no
assurance that a portfolio company will be able to predict accurately the future capital
requirements necessary for success or that additional funds will be available from any source.
Bridge Financings. From time to time, a client may lend with respect to an investment or a
potential investment on a short-term, unsecured basis in anticipation of a future issuance of
equity or long-term debt securities. Such bridge loans would typically be convertible into a more
permanent, long-term security. However, for reasons not always in such client’s control, such
long-term securities may not be issued and such bridge loans may remain outstanding. In such
event, the interest rate on such loans may not adequately reflect the risk associated with the
unsecured position taken by that client.
Controlling Interests. Because of its equity ownership, representation on the board of directors
and/or contractual rights, a client may often be considered to control, participate in the
management of, or influence the conduct of portfolio companies. The designation of HCA’s
professionals as directors and exercise of control over a portfolio company may impose
additional risks of liability for environmental damage, product defects, pension and other fringe
benefits, failure to supervise management, violation of fiduciary duties, violation of laws and
governmental regulations (including securities laws), and other types of liability, for which the
limited liability generally afforded to investors may be ignored. If these liabilities were to arise,
a client may suffer a significant loss, exposing the assets of such client to claims by a portfolio
company, its other security holders, its creditors, or governmental agencies, which may exceed
the value of such client’s initial investment in that portfolio company.
please register to get more info
To HCA’s knowledge, after due inquiry, none of HCA, its affiliates, or any of their respective
management personnel has been involved in, or subject to, any disciplinary events or legal
actions that would be material to a client’s or prospective client’s evaluation of HCA’s advisory
business or the integrity of HCA’s management.
please register to get more info
Neither HCA nor any member of its management is registered, or has an application pending to
register, as a broker-dealer, a registered representative of a broker-dealer, a futures commission
merchant (an “FCM”), a commodity pool operator (a “CPO”), a commodity trading advisor
(“CTA”), or an associated person of a registered FCM, CPO, or CTA. HCA and certain of its
affiliates act as CPOs for their clients, but they are exempt from registration with the Commodity
Futures Trading Commission (the “CFTC”) pursuant to CFTC Rule 4.13(a)(3) under the U.S.
Commodity Exchange Act. This exemption is based primarily upon the clients’ limited
commodity interest trading. Unlike registered CPOs, HCA and its relevant affiliates are not
required to deliver to investors disclosure documents or certified annual reports contemplated by
CFTC rules applicable to registered CPOs. Likewise, HCA and certain of its affiliates act as
CTAs for some of their clients, but are exempt from registration as CTAs and therefore are not
required to satisfy certain requirements contemplated by CFTC rules applicable to registered
CTAs.
Certain members of HCA’s management constitute and/or serve as the directors of the general
partners of certain of the Funds. Such relationships create a potential conflict of interest, which
HCA seeks to address in a number of ways, including by disclosing the terms of the relevant
partnership agreement to the Funds’ investors.
All qualifying HCA personnel (and qualifying personnel of the non-U.S affiliates discussed in
Item 4) are treated as “access persons” by HCA within the meaning of Rule 204A-1 under the
Advisers Act, and are subjected to HCA’s Code of Ethics. Please see Item 11, “Code of Ethics,
Participation or Interest in Client Transactions, and Personal Trading” below for additional
information about HCA’s Code of Ethics.
An HCA affiliate, Hillhouse Capital Management, Ltd. (“HCM”) is also an SEC-registered
investment adviser. While HCA and HCM may, from time to time, invest in similar strategies or
companies, HCA-advised clients generally focus on publicly-listed (or similarly liquid)
investment opportunities, while HCM-advised clients largely focus on private (or otherwise less
liquid) investment opportunities, including venture capital, private equity, private debt and
buyout transactions. Therefore, investment results may differ as between HCA’s clients and
HCM’s clients. To address these potential conflicts of interests, HCA has adopted policies and
procedures, including a Code of Ethics. Please see Item 11, “Code of Ethics, Participation or
Interest in Client Transactions, and Personal Trading,” below for additional information
regarding HCA’s Code of Ethics.
HCA and HCM use shared personnel for certain services, including personnel of certain non-
U.S. affiliates, as discussed in Item 4 above. Shared personnel may include back office
personnel as well as professionals who provide portfolio advice. Such shared personnel may
have conflicts of interest in allocating their time and resources between HCA and HCM.
Different performance or management compensation structures or incentives may apply to
shared personnel, which may also create a conflict of interest. HCA has adopted policies and
procedures, including a Code of Ethics, to address these potential conflicts of interest.
Different performance and management fees may be charged for substantially similar products
HCA manages or advises, which may also create a conflict of interest. Please see Item 5, “Fees
and Compensation” above for information regarding how HCA is compensated by its clients, the
potential conflict of interest created by allocating investment opportunities among clients, and
how HCA addresses the potential conflict of interest.
HCA does not recommend or select third-party investment advisers for its clients. None of
HCA, HCM, or any other affiliate receives compensation, directly or indirectly, from any of the
others for any recommendation of the other. In addition, none of HCA, HCM, or any other
affiliate, directly or indirectly, pays or receives compensation to or from third parties in
connection with recommending advisory services.
Other conflicts not discussed above may arise in connection with HCA’s advisory business.
please register to get more info
PERSONAL TRADING General Code of Ethics HCA expects its employees to be responsible for maintaining the highest ethical standards when
conducting business. In keeping with these standards, HCA’s employees must always place its
clients’ interests ahead of their own. Moreover, HCA’s employees should adhere to the spirit as
well as the letter of the law and be vigilant in guarding against anything that could
inappropriately skew their judgment.
Pursuant to Rule 204A-1 under the Advisers Act, HCA has adopted a Code of Ethics (the
“Code”) which sets forth standards of business and personal conduct for all HCA employees, and
addresses conflicts of interest that may arise from personal trading by employees or gifts and
entertainment received or provided by employees. The Code sets forth, among other things,
standards for the purpose of deterring wrongdoing and promoting: (i) honest and ethical
reporting; (ii) full, fair, accurate, timely, and understandable disclosure in reports and documents;
(iii) compliance with applicable laws, rules, and regulations; (iv) prompt internal reporting of
violations of the Code; and (v) accountability for adherence to the Code. Clients or potential
clients may obtain a copy of the Code free of charge by writing to HCA’s Chief Compliance
Officer at the address on the cover page of this Brochure.
As discussed in Item 10, qualifying personnel of the non-U.S affiliates discussed in Item 4 are
treated as “access persons” by HCA within the meaning of Rule 204A-1 under the Advisers Act,
and are subjected to HCA’s Code of Ethics.
Interest in Client Transactions Clients of HCA and its affiliates (such persons, the “Other Hillhouse Investors”) may hold
investments similar to or the same as those made or proposed to be made by other of HCA’s
clients. Investments held by Other Hillhouse Investors may be in the same or similar securities
as those held by HCA’s other clients, but acquired at different times, at lower or higher prices or
valuations, and on different terms than those upon which HCA’s clients acquire an investment.
The different prices paid for, or terms of, securities held by the Other Hillhouse Investors may
create conflicts of interest. HCA has adopted an aggregation and allocation policy to help assure
investment opportunities are recommended or allocated in a fair and equitable manner. As
described more fully in Item 5 under “Fees and Compensation,” HCA takes various factors into
account in making recommendation and allocation decisions.
Please see Item 5, “Fees and Compensation,” and Item 10, “Other Financial Industry Activities
and Affiliations,” above for a discussion of the potential conflict of interest created by allocating
investment opportunities among client accounts and how HCA addresses the potential conflict of
interest.
Personal Trading The Code is designed to assure that the personal securities transactions, activities, and interests
of HCA’s employees do not interfere with their judgment in advising HCA’s clients. HCA
discourages its employees from personal trading due to the conflicts of interest (real and
apparent) that such trading may present. Employees must seek pre-clearance for certain
reportable personal securities transactions and provide post-trading details of all approved
personal trades. Employees also must provide HCA with detailed information regarding their
reportable personal securities holdings, which they must update on a quarterly basis. Although
employees are not prohibited from personal trading, employees are prohibited from short-term
trading or speculation, and employees must present any investment opportunities suitable for any
investment strategy of HCA’s clients to such clients prior to engaging in any transaction related
thereto for personal benefit. To minimize the risk of potential conflicts of interests, employees
and their immediate family members may not, directly or indirectly, make personal trades in any
security, company, asset, or investment product (i) located in or having a substantial business
relation to Asia or (ii) under research, traded in, or contemplated to be traded in by HCA, in each
case without the consent of the Chief Compliance Officer.
Service on Boards of Directors Representatives of HCA, HCM, or their other affiliates may, from time to time, serve on the
boards of directors of portfolio and other companies. A HCA representative serving as a director
for a company has fiduciary duties to the company, as well as to HCA’s clients. These separate
fiduciary obligations may create conflicts of interest that must be mitigated to ensure the HCA
representative serving as director does not breach his or her fiduciary obligations. In addition, if
HCA obtains material, non-public information by virtue of a representative serving as a director
of a company, HCA may be precluded from trading or making a recommendation with respect to
the securities of such company. HCA has adopted internal policies and procedures to address
conflicts of interest that may arise in connection with service on the board of directors of a
company.
Other Business Ventures HCA, its affiliates and its clients may engage in other business ventures to the extent not
prohibited by agreements with its clients, independently or with others, including ventures
involving investing in securities or managing or participating in other investment funds, or
pursuing co-investments with HCA’s clients or otherwise investing in portfolio companies
independently of its clients. Other ventures undertaken by HCA and its affiliates may be
competitive with its clients. Conflicts of interest may arise as a result of such activities,
including in allocating management time, services or functions and allocating investment
opportunities.
In addition, as discussed above, HCA and its affiliates may provide investment advisory services
to Co-Investment Arrangements or portfolio companies, and may also invest directly or
indirectly in investment opportunities. HCA recognizes the potential for conflicts in these
situations and relies upon its allocation and other internal policies and procedures to ensure fair
and equitable allocation of investment opportunities, and to address other potential conflicts of
interest.
Other conflicts not discussed above may arise in connection with the management and operation
of HCA’s clients.
please register to get more info
HCA provides discretionary and non-discretionary advice to its clients. HCA may make broker
recommendations to certain of these clients. HCA may choose various brokers for more efficient
and/or less expensive transactions, or for non-financial relationship reasons. HCA endeavors to
recommend or select brokers that provide the best execution for securities transactions so that a
client’s total costs or proceeds in each transaction are the most favorable under the circumstances
(“Best Execution”). In recommending and/or selecting brokers to effect portfolio transactions,
HCA considers various factors, including, without limitation: price; quality of execution,
including the reliability, promptness, level of accuracy and confidentiality in executing orders;
extensiveness of the broker’s distribution network; commission rates or other transaction costs;
HCA’s access to the broker’s trading desk; the broker’s familiarity with HCA’s investment
practices; and the value of certain brokerage or research services. HCA does not consider
whether it receives referrals from a broker-dealer or third party in recommending or selecting a
broker. In any event, non-discretionary account clients are not under any obligation to select the
broker that HCA has recommended.
Directed Brokerage Clients may sometimes request that HCA use a particular broker-dealer to effect transactions in
recognition of services the clients receive from the broker-dealer or from a third party.
Agreement to any such request by a client must be pre-approved by HCA’s Chief Compliance
Officer. A client’s direction of brokerage services may cost the client more money and may
prevent the client from receiving the most favorable execution of the client’s transactions.
Soft Dollar Arrangements HCA may enter into arrangements whereby HCA receives research or other products or services
(other than execution) from a broker or other third party in connection with client securities
transactions, known as “soft dollar benefits.” These soft dollar benefits would be received in
connection with commission fees paid to those brokers to execute client transactions. These
research products and services would be intended to provide HCA with valuable research and
services that HCA would otherwise have to produce or purchase from third parties with its own
funds.
Any transaction in which soft dollar benefits are being received will be carefully evaluated to
determine that the transaction complies with HCA’s duty to seek Best Execution. However, as a
result of any soft dollar benefits HCA receives, HCA may have an incentive to select or
recommend a broker based on receipt of soft dollar benefits.
Section 28(e) of the Securities Exchange Act of 1934 establishes a safe harbor allowing
investment managers to use client funds, by way of commission dollars, to purchase certain
“brokerage and research” services. Pursuant to this safe harbor, the brokerage and research
services must provide HCA with lawful and appropriate assistance in the performance of its
investment decision-making responsibilities. Further, HCA will make a good faith determination
that the amount of commissions paid by clients is reasonable in light of the value of the
brokerage or research services received. This means that clients may pay commissions to a
broker in an amount greater than the amount another broker might charge.
HCA believes that the products or services it may obtain through soft dollar arrangements would
benefit all of its relevant client accounts, rather than benefitting just one account. HCA currently
does not require soft dollar benefits to be allocated proportionately to the amount of soft dollar
benefits generated by each client account. Therefore, it is possible that such soft dollar benefits
may provide a benefit to some clients who have not generated a proportionate share of
commissions used to pay for these benefits. However, it is also possible that clients may benefit
from these arrangements to a greater extent than the commissions they generated.
HCA has instituted certain procedures governing soft dollar benefits. Soft dollar benefits may be
received from a broker in consideration of directing transaction business on behalf of a client to
the broker only if:
The soft dollar products or services fall within the Section 28(e) safe harbor;
The soft dollar products or services are of demonstrable benefit to HCA’s clients;
HCA seeks to affirm that the soft dollar product or service assists in the investment
decision-making process and the commissions paid are reasonable in relation to the
products or services received;
Transaction execution is consistent with Best Execution standards and brokerage rates are
not in excess of customary full-service brokerage rates;
Disclosure is made to HCA’s clients of its practices for receiving the soft dollar products
or services; and
The client(s) has consented in writing to the receipt of soft dollar products or services.
Trade Aggregation HCA generally aggregates its client orders when doing so will result in a better overall price for
its clients’ trades and as otherwise consistent with the terms of its allocation policies.
Aggregation or “bunching” describes a procedure whereby an investment manager combines the
orders of two or more clients into a single order for the purpose of obtaining better prices and
lower execution costs. Aggregation opportunities generally arise when more than one client is
capable of purchasing or selling a particular security based on investment objectives, net asset
value, available cash, lifespan of HCA’s clients and other factors. Unless inconsistent with or
prohibited by local law, regulations or exchange rules, HCA will not aggregate orders among
clients of HCA and/or its affiliates.
HCA does not aggregate or bunch certain client orders of A Share Investments since A Share
Investments are generally processed separately with respect to each client.
please register to get more info
HCA reviews and evaluates its clients’ investment objectives and performance on a quarterly
basis. HCA also reviews strategies to ensure compliance with investment objectives and
restrictions. Reviews are primarily conducted by the relevant portfolio manager and may
periodically be conducted by an Investment Committee that is comprised of HCA’s Chief
Investment Officer and other senior members of HCA’s research team.
Client Reports HCA’s Fund investors receive an annual report containing audited financial statements following
the end of the Fund’s fiscal year. Fund investors also receive relevant tax information for the
Fund in which they are invested. In addition, HCA’s third-party administrator delivers to
investors an unaudited statement of an estimate of the account and account balance(s) and any
capital contributions or withdrawals since the preceding month-end generally within 30 days
after the end of each calendar month or as soon thereafter as is reasonably possible. These
written financial statements and reports typically do not include a listing of portfolio
investments.
In connection with making QFII Investments, HCA’s clients are required to engage a custodian
to assist with holding client assets, reporting, and other related activities. HCA urges clients to
carefully review statements and reports received from their broker-dealers, banks and other
qualified custodians and to compare any account statements received from HCA against
information received from their qualified custodian. To the extent requested by HCA’s managed
account clients’ or its managed account clients’ custodian, HCA provides a written copy of its
transaction reports or records related to such client’s accounts to assist such client or clients’
custodian with reconciliation of information. Within 30 days after the end of each calendar
month or as soon thereafter as is reasonably possible, HCA or one of its affiliates delivers an
unaudited statement of an estimate of such client’s account and account balance(s) and any
capital contributions or withdrawals by such client since the preceding month-end.
please register to get more info
Neither HCA nor a related person of HCA, directly or indirectly, compensates any person for
client referrals. Should HCA determine to enter into a solicitation arrangement for client
referrals, HCA will disclose the arrangement in writing as required by Rule 206(4)-3 under the
Advisers Act and will comply with all other applicable requirements of the Rule.
No person, other than HCA’s clients, provides HCA with an economic benefit for providing
advisory services to its clients. Please see Item 12, “Brokerage Practices” above for a discussion
of certain soft dollar benefits that HCA may receive in connection with certain brokerage
relationships.
A related person of HCA may, from time to time, serve as a director on the board of a public or
private company in which one or more of HCA’s clients invest. HCA may receive director’s
fees in connection with such service. Item 11, “Code of Ethics, Participation or Interest in Client
Transactions, and Personal Trading,” further describes HCA’s process for addressing conflicts of
interest created by its related persons serving as directors.
please register to get more info
HCA may be deemed to have custody over certain of its clients’ assets under Rule 206(4)-2 of
the Advisers Act (the “Custody Rule”) because of its authority to access client assets and its role
as a general partner of a Fund. The term “custody” is defined under the Custody Rule as
holding, directly or indirectly, client funds or securities, or having any authority to obtain
possession of them. HCA does not physically hold client assets. Instead, HCA maintains client
securities and funds over which it has custody with a “qualified custodian” in accordance with
the Custody Rule. Client funds and securities are held with a bank, broker-dealer or other
independent, qualified custodian. HCA’s Chief Compliance Officer is responsible for ensuring
that any qualified custodian with custody of client assets is properly qualified. Further, HCA
may satisfy the audit provision of Rule 206(4)-2 under the Advisers Act - the Custody Rule -
through an annual audit of the relevant clients. Where required, audited financial statements are
prepared and delivered to underlying investors in accordance with the Custody Rule. Please see
Item 13, “Review of Accounts” above for further information about client reports and account
statements delivered to underlying Fund investors.
please register to get more info
HCA provides advisory services to managed account clients on both a discretionary and non-
discretionary basis. As noted above under Item 7, “Types of Clients,” all clients must enter into
written investment advisory agreements with HCA before establishing an advisory relationship
with HCA.
Pursuant to written investment management agreements with clients and the organizational
documents of the Funds, HCA has discretionary authority to manage assets on behalf of the
Funds and its other clients, including authority to determine which investments are bought and
sold and the amounts appropriate for each client. Certain of HCA’s clients may place limits on
HCA’s investment advice; any limitation on HCA’s authority is described in the written
investment management agreements and/or the Funds’ governing documents. HCA only
purchases and sells securities or other financial instruments consistent with the Funds’ and its
other clients' objectives.
please register to get more info
HCA has and will accept proxy voting authority to vote client securities. This creates a potential
conflict of interest because of the possibility of HCA voting client securities to further its own
interests at the expense of its clients’ interests. HCA takes seriously its responsibility to exercise
proxies on behalf of clients and have adopted written policies and procedures to do so in a
manner consistent with Rule 206(4)-6 promulgated under the Advisers Act. These policies and
procedures are reasonably designed to ensure that proxies are voted in the best interest of HCA’s
clients, which generally means voting proxies with a view to enhancing the value of client
securities.
The financial interest of HCA’s clients is the primary consideration in determining how proxies
should be voted. Further, as the decision to invest in a company normally represents confidence
in the company’s management, HCA will typically give serious consideration to management
recommendations. HCA will generally support management recommendations regarding
internal operations and those without significant economic effects. Conversely, management
proposals that are likely to have significant economic effects, involve management interests or
where HCA lacks confidence in the management team will be subject to greater scrutiny on a
case-by-case basis. The following is a brief summary of principles, rather than rules, that reflect
the long-term approach that guides (but does not obligate) HCA’s investment and proxy voting
decisions regarding common proxy proposals.
1. Board of Directors: HCA will generally support resolutions that promote the
effectiveness of boards in acting in the best interest of shareholders. HCA generally
supports the election of a majority of independent directors.
2. Auditors and Auditor Compensation: Where all members of a company audit committee
are independent, HCA will generally support the election of directors, the appointment of
auditors, and the approval of the auditor compensation recommended by the board of
directors.
3. Changes in Capitalization: HCA recognizes the need for the management of a company
to have flexibility to issue or repurchase shares to meet changing financial conditions.
HCA will generally support changes in capitalization when a reasonable need for change
is demonstrated. HCA is, however, aware that new shares may dilute the ownership
interest of shareholders, and HCA will not generally support changes resulting in
excessive dilution of existing shareholder value.
4. Corporate Restructuring, Mergers, and Acquisitions: HCA believes proxy votes dealing
with corporate reorganizations are an extension of the investment decision. Accordingly,
HCA will analyze such proposals on a case-by-case basis, weighing heavily the views of
its research analysts that cover the company and its investment professionals managing
the portfolios in which the stock is held.
5. Management Compensation: HCA’s goal is to support compensation arrangements that
are tied to long-term corporate performance and shareholder value. These arrangements
should better align management’s interests with those of shareholders and should induce
management to purchase and hold equity in the company. Stock option plans that are
overly generous or excessively dilutive to other shareholders generally will not be
supported.
6. Other Issues: HCA will address business issues specific to a company or those raised by
shareholders of a company on a case-by-case basis with a focus on the potential impact of
the vote on value for its clients.
Procedurally, HCA will take reasonable measures under the circumstances to obtain knowledge
of meetings and other events giving rise to solicitation of proxies, assure that proxies are
received in sufficient time for HCA to take action, vote proxies, and return the proxies to the
parties soliciting them in time to be counted. Clients may direct (in certain cases) the vote of
HCA in a particular solicitation, obtain information from HCA about how it voted clients’
securities and obtain a copy of HCA’s proxy voting policies and procedures by writing to
Hillhouse Capital Advisors, Ltd., Attn: Chief Compliance Officer, at the address on the cover
page of this Brochure.
If a HCA representative serves on the board of directors for a portfolio company in which a
client invests, unique conflicts of interest in relation to proxies may exist. In such circumstances,
HCA’s Chief Compliance Officer or its designee will undertake a review prior to any vote by the
proxy recipient to determine whether a material conflict of interest exists between the applicable
HCA representative and the interests of the client, or between the HCA representative and the
client and company shareholders. In the event a material conflict of interest is identified, the
Chief Compliance Officer or his or her designee will take such steps as he or she deems
necessary to determine how to vote the proxy in the best interests of the relevant client. In each
instance, when exercising their voting discretion, HCA’s representatives will seek to avoid any
direct or indirect conflict of interest between the client(s) and their voting decisions.
please register to get more info
There is no financial condition that is reasonably likely to impair HCA’s ability to meet its
contractual commitments to clients.
please register to get more info
Open Brochure from SEC website